| 引用本文:王芳1，陈洁1，刘宇涵1，庞硕勋2，杨海燕3.通心络胶囊联合倍他乐克对冠心病稳定型心绞痛患者心功能的影响[J].世界中医药,2021,(17):. |
|
| 通心络胶囊联合倍他乐克对冠心病稳定型心绞痛患者心功能的影响 |
| Effects of Tongxinluo Capsuless Combined with Betaloc on Cardiac Function in Patients with Stable Angina Pectoris of Coronary Heart Disease |
| 投稿时间：2021-07-05 |
| DOI：10.3969/j.issn.1673-7202.2021.17.016 |
| 中文关键词: 通心络胶囊 倍他乐克 冠心病 稳定型心绞痛 动脉粥样硬化 心肌缺血 血脂 中医 |
| English Keywords:Tongxinluo Capsules Betaloc Coronary heart disease Stable angina pectoris Atherosclerosis Myocardial ischemia Blood lipid Traditional Chinese medicine |
| 基金项目:国家自然科学基金项目（30673187）——高危因素致颈动脉粥样硬化患者甲襞微循环病变特征及通络干预研究 |
|
| 摘要点击次数: 199 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：探讨通心络胶囊联合倍他乐克对冠心病稳定型心绞痛患者心功能的影响。方法：选取2018年1月至2020年1月河北以岭医院收治的冠心病稳定型心绞痛患者84例作为研究对象，按照随机数字表法分为对照组和观察组，每组42例。对照组在常规治疗基础上给予倍他乐克。观察组在对照组治疗基础上给予通心络胶囊治疗。对比2组的疗效、中医证候评分、超声心动图指标［左心室射血分数（LVEF）、左心室舒张末期内径（LVEDD）、左心室收缩末内径（LVESD）］、血脂指标［总胆固醇（TC）、三酰甘油（TG）、低密度脂蛋白胆固醇（LDL-C）、高密度脂蛋白胆固醇（HDL-C）］、心绞痛发作情况、不良反应发生率。结果：观察组的治疗效果好于对照组（P<0.05）。2组治疗后的中医证候评分、LVEDD、LVESD、TG、TC、LDL-C、心绞痛发作频率、发作持续时间降低，LVEF、HDL-C增高。观察组的中医证候评分、LVEDD、LVESD、TG、TC、LDL-C、心绞痛发作频率、发作持续时间低于对照组，LVEF、HDL-C高于对照组（均P<0.05）。2组的不良反应发生率比较，差异无统计学意义（P>0.05）。结论：通心络胶囊联合倍他乐克治疗冠心病稳定型心绞痛患者，可提高临床疗效，改善心功能，降低血脂水平，减少心绞痛的发作，安全性良好。 |
| English Summary: |
| To investigate the effects of Tongxinluo Capsules combined with betaloc on cardiac function in patients with stable angina pectoris of coronary heart disease.Methods:A total of 84 patients with stable angina pectoris of coronary heart disease admitted to Hebei Yiling Hospital from January 2018 to January 2020 were selected as research objects.According to random number table method，they were divided into a control group and an observation group，with 42 cases in each group.The control group was given Betaloc on the basis of conventional treatment.The observation group was given Tongxinluo Capsules treatment on the basis of the treatment of the control group.The efficacy，TCM symptom score，echocardiographic index［left ventricular ejection fraction(LVEF)，left ventricular end diastolic diameter(LVEDD)，left ventricular end systolic diameter(LVESD)］，blood lipid index［total cholesterol(TC)，triglycerides(TG)，low-density lipoprotein cholesterol(LDL-C)，high-density lipoprotein cholesterol(HDL-C)］，angina pectoris，adverse reactions were compared.Results:The treatment effect of the observation group was better than that of the control group(P<0.05).After treatment，the TCM symptom scores，LVEDD，LVESD，TG，TC，LDL-C，angina pectoris frequency，duration of attacks of the two groups all decreased，and LVEF and HDL-C increased.The TCM syndrome score，LVEDD，LVESD，TG，TC，LDL-C，angina pectoris frequency and duration of attacks of the observation group were lower than those of the control group，while LVEF and HDL-C were higher than those of the control group(all P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the 2 groups(P>0.05).Conclusion:Tongxinluo Capsules combined with Betaloc in the treatment of patients with stable angina pectoris of coronary heart disease can improve clinical efficacy，improve heart function，reduce blood lipid levels and the onset of angina pectoris，and has good safety. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
